A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

Conditions: Endometrial Cancer Interventions: Drug: BNT323/DB-1303; Drug: Doxorubicin; Drug: Paclitaxel Sponsors: BioNTech SE; DualityBio Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials